Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,236.00-0.99%ETH$2,242.59-0.43%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Cardinal Health, Inc. logo

NYSE · CAH

Cardinal Health, Inc.

Healthcare · Medical - Distribution

$251.09

Down-$0.61 (-0.24%)

Updated Oct 30, 2026, 11:01 PM

SID Score

6.9/10

Composite research score

Smart Money

58/100

Neutral

Market cap
47.1B
P/E ratio
29.58
Dividend yield
1.01%
52-week range
$180.45 – $259.21
Volume
1.74M
Avg. volume
2.49M

Price performance · CAH

CAH price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

CAH closed at $251.09 after 21 trading sessions, up 9.13% for the selected period.

Last close
$251.09
Period change
+9.13%
Period low
$228.30
Period high
$257.55
Daily close
View OHLC price history
CAH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$248.32$251.63$246.99$251.091.74M
Oct 28, 2026$243.91$247.14$243.49$244.761.1M
Oct 27, 2026$250.39$251.45$246.39$246.451.63M
Oct 26, 2026$250.50$254.37$249.955$251.541.69M
Oct 23, 2026$254.93$255.64$249.24$249.571.67M
Oct 22, 2026$258.21$259.21$254.82$255.641.5M
Oct 21, 2026$256.36$259.09$254.74$257.461.59M
Oct 20, 2026$255.00$257.55$252.36$257.551.91M
Oct 19, 2026$252.04$254.4678$249.54$252.653.78M
Oct 16, 2026$254.81$255.56$251.95$254.061.34M
Oct 15, 2026$252.00$254.00$249.27$253.712.06M
Oct 14, 2026$240.90$247.93$240.76$247.741.97M
Oct 13, 2026$240.78$241.18$236.19$239.721.35M
Oct 12, 2026$238.93$240.10$233.88$238.081.23M
Oct 9, 2026$237.79$239.81$236.37$237.571.03M
Oct 8, 2026$231.50$241.96$231.25$238.961.54M
Oct 7, 2026$233.61$235.97$230.61$232.161.1M
Oct 6, 2026$233.69$235.19$231.635$233.441.15M
Oct 5, 2026$229.11$234.18$228.59$233.121.72M
Oct 2, 2026$229.54$231.10$224.45$228.301.86M
Oct 1, 2026$227.55$235.95$227.3993$230.091.91M

Latest CAH news

The latest Smart Investors Daily articles mentioning CAH.

Stock researchCompany · Overview

CAH research

Overview

Company profile and research snapshot.

Company profile

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$211.22
Implied upside
—
Analysts
13
CAH recent ratings
DateFirmRatingTarget
Oct 20, 2026MizuhoOutperform—
Oct 16, 2026UBSBuy—
Aug 19, 2026RBC CapitalOutperform—
Aug 13, 2026JP MorganNeutral—
Aug 13, 2026TD CowenBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Should Upcoming Earnings Expectations Require Action From Cardinal Health Stock Investors?

Cardinal Health is preparing to report earnings in early November 2026, with forecasts pointing to higher earnings per share and revenue compared with the prior year. The upcoming results are expected to highlight how the business is converting pharmaceutical distribution and medical product demand into profit, with analyst sentiment serving mainly as a supporting signal rather than the primary focus. We will now evaluate how Cardinal Health's investment narrative holds up against these...

Yahoo · Oct 22, 2026

Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View

Cardinal Health earnings event puts the spotlight on sentiment Cardinal Health (CAH) heads into its planned November 5, 2026 earnings release with fresh attention after Mizuho raised expectations and the stock recently pushed through one technical entry and began testing another. Over the past year, Cardinal Health has moved from a quiet compounder to a momentum story, with a 30-day share price return of 14.05% and a 1-year total shareholder return of 62.92% that builds on an approximately 5x...

Yahoo · Oct 21, 2026

Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One

Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Disposable Specimen Container Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global disposable specimen container market is experiencing strong growth as healthcare providers, diagnostic laboratories and research organizations prioritize hygienic sample collection, specimen integrity and infection control. The market is projected to increase from $2.66 billion in 2025 to $2.89 billion in 2026, representing a compound annual

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By